Saccade latency and accuracy reflect different features of eye-movement control: latency captures how quickly a response begins, whereas accuracy indicates how closely the eye reaches the intended location. Their value comes from linking behavior to coordinated cortical, cerebellar, and brainstem circuits rather than treating a single eye-movement measure as a complete neural readout.
Smooth-pursuit gain and fixation stability probe complementary aspects of oculomotor function. Smooth-pursuit gain reflects performance during visual tracking, while fixation stability addresses how consistently the eyes remain controlled when maintaining a fixation. These measures can be interpreted alongside saccade latency, accuracy, and antisaccade errors to separate tracking and holding demands rather than relying on one parameter.
Antisaccade errors add another measure of performance to the biomarker set. In combination with saccade latency and accuracy, they broaden characterization of attention and sensorimotor control that may not be captured by a single movement feature. Their interpretation remains tied to the coordinated brain circuits engaged by the visual stimulus.
An eye-tracking assessment presents visual stimuli and records the resulting eye movements for quantitative analysis. The system can derive saccade latency and accuracy, smooth-pursuit gain, fixation stability, and antisaccade errors from these responses. This measurement framework lets investigators examine several components of brain function and dysfunction using objective, noninvasive observations of eye behavior.
Oculomotor biomarkers support research across Parkinson’s disease, schizophrenia, multiple sclerosis, and traumatic brain injury. Their value is not limited to naming a diagnosis: the measures can characterize attention, sensorimotor control, and neural connectivity across these contexts. This makes them useful for examining how brain-related dysfunction appears in different conditions.
Repeated collection makes it possible to examine whether measured eye-movement features change over time. Because the measures can be collected objectively and repeatedly, investigators may use them for disease monitoring and for evaluating treatment-related changes. They may also contribute to early detection research and the characterization of brain dysfunction.